Back to BCRX
VANGUARD GROUP INC BCRX Position History
BioCryst Pharmaceuticals, Inc. • Healthcare
Quarters held
20
Latest value
$160.1M
Q4 2025
Peak value
$179.6M
First seen
Q1 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2025 | $635K |
| Q1 2025 | $1.5M |
| Q1 2025 | $1.1M |
| Q1 2025 | $342K |
| Q1 2025 | $158.9M |
| Q2 2025 | $823K |
| Q2 2025 | $1.8M |
| Q2 2025 | $1.5M |
| Q2 2025 | $408K |
| Q2 2025 | $179.6M |
| Q3 2025 | $632K |
| Q3 2025 | $152.7M |
| Q3 2025 | $10.5M |
| Q3 2025 | $346K |
| Q3 2025 | $1.2M |
| Q4 2025 | $649K |
| Q4 2025 | $11.3M |
| Q4 2025 | $1.3M |
| Q4 2025 | $355K |
| Q4 2025 | $160.1M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q4 2025 | $160.1M | 20.53M | — | — |
| Q4 2025 | $355K | 45.5K | — | — |
| Q4 2025 | $1.3M | 162.8K | — | — |
| Q4 2025 | $11.3M | 1.45M | — | — |
| Q4 2025 | $649K | 83.1K | — | — |
| Q3 2025 | $1.2M | 162.8K | — | — |
| Q3 2025 | $346K | 45.5K | — | — |
| Q3 2025 | $10.5M | 1.39M | — | — |
| Q3 2025 | $152.7M | 20.11M | — | — |
| Q3 2025 | $632K | 83.2K | — | — |
| Q2 2025 | $179.6M | 20.04M | — | — |
| Q2 2025 | $408K | 45.5K | — | — |
| Q2 2025 | $1.5M | 162.8K | — | — |
| Q2 2025 | $1.8M | 203.8K | — | — |
| Q2 2025 | $823K | 91.9K | — | — |
| Q1 2025 | $158.9M | 21.18M | — | — |
| Q1 2025 | $342K | 45.5K | — | — |
| Q1 2025 | $1.1M | 151.4K | — | — |
| Q1 2025 | $1.5M | 196.5K | — | — |
| Q1 2025 | $635K | 84.7K | — | — |
Other funds holding BCRX
$151.9M
$151.9M
$116.2M
$88.8M
$86.4M
$76.5M
$76.2M